Skip to main content

Peer Review reports

From: Development of dermatomyositis after anti-transcriptional intermediary factor 1-γ antibody seroconversion during treatment for small cell lung cancer

Original Submission
17 Nov 2021 Submitted Original manuscript
25 Nov 2021 Author responded Author comments - Yuki Sato
Resubmission - Version 2
25 Nov 2021 Submitted Manuscript version 2
1 Dec 2021 Author responded Author comments - Yuki Sato
Resubmission - Version 3
1 Dec 2021 Submitted Manuscript version 3
16 Jan 2022 Reviewed Reviewer Report
27 Jan 2022 Reviewed Reviewer Report - Takashi Matsushita
1 Mar 2022 Author responded Author comments - Yuki Sato
Resubmission - Version 4
1 Mar 2022 Submitted Manuscript version 4
2 Mar 2022 Reviewed Reviewer Report
19 Apr 2022 Reviewed Reviewer Report
25 Apr 2022 Author responded Author comments - Yuki Sato
Resubmission - Version 5
25 Apr 2022 Submitted Manuscript version 5
Publishing
27 Apr 2022 Editorially accepted
12 May 2022 Article published 10.1186/s12890-022-01974-4

You can find further information about peer review here.

Back to article page